Table 1

Age distribution of people entering the HIV cohort, the percentage who were female, and the number of people who entered the reference cohort*

Age (years)HIV cohort
Number (% of total)
Female (%)Reference cohort
Number
0–4139(0.7)44.6112 355
5–9168(0.8)45.2145 618
10–14138(0.7)57.2113 372
15–19173(0.8)59.0166 198
20–24653(3.1)44.4200 079
25–292136(10.1)43.9264 771
30–344066(19.2)36.9377 462
35–394792(22.6)29.6444 962
40–443701(17.5)24.9390 356
45–492228(10.5)20.6329 573
50–541293(6.1)18.6345 117
55–59776(3.7)17.4375 702
60–64480(2.3)16.3377 503
65–69274(1.3)21.2387 109
70–7498(0.5)21.4397 229
75–7937(0.2)27.0385 998
80–8422(0.1)22.7282 933
85+33(0.2)45.5202 159
All ages21 207(100)30.25 298 496
  • Note that all eligible controls were used (there is no merit in discarding controls to equalise numbers in each age group); and that all analyses were done within strata (eg, the 112 355 controls aged 0–4 were compared with the 139 in the HIV cohort). The expected numbers in each stratum were then summed to give age-standardised comparisons of expected and observed numbers with MS in each cohort.

  • *The reference cohort consisted of people admitted with the following conditions coded under the Office of Population, Censuses and Surveys code (OPCS) edition 4 for operations and the ICD revision 10 for diagnoses: adenoidectomy (OPCS4 E20), tonsillectomy (F34+F36), appendectomy (H01–H03), total hip replacement (W37–W39), total knee replacement (W40–W42), cataract (ICD 10 H25), otitis externa/media (H60–H67), varicose veins (I83), haemorrhoids (I84), deflected septum, nasal polyp (J33+J34.2), inguinal hernia (K40), gallbladder disease (K80–K81), in–growing toenail and other diseases of nail (L60), sebaceous cyst (L72.1), bunion (M20.1), internal derangement of knee (M23).

  • MS, multiple sclerosis.